CBX3P6

Across TCGA pan-cancer cohorts, CBX3P6 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated CBX3P6 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CBX3P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CBX3P6 expression acts as an unfavorable survival marker, although some lineages such as SKCM and BLCA show a favorable association.

COAD, KIRP, and STAD are the cancer types where CBX3P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.039	0.783	<.001	72	view →
KIRP	DFS	Tertile	II,III,IV	0.038	0.783	<.001	45	view →
STAD	OS	Tertile	IV	0.191	0.543	.002	36	view →
KIRC	DFS	Tertile	IV	0.156	0.630	<.001	36	view →
LIHC	OS	Tertile	III,IV	0.394	0.639	.026	30	view →
LGG	OS	Tertile	All	0.500	0.911	<.001	18	view →
UCEC	DFS	Tertile	All	0.501	0.686	.014	18	view →
SKCM	OS	Tertile	All	0.916	0.766	.002	15	view →
BLCA	OS	Tertile	IV	0.801	0.563	.026	12	view →
BRCA	DFS	Tertile	All	0.984	0.945	.043	12	view →
MESO	OS	Tertile	All	0.231	0.549	.039	9	view →
LUSC	DFS	Tertile	III,IV	0.395	0.677	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

CBX3P6–COAD (OS)

Open the COAD breakdown →